Metabolic reprogramming of pulmonary fibrosis

Jiaxin Li(Central South University), Jiali Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qiuhuan Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoxuan Zhai(Shandong University), Shengchuan Cao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiao Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Pharmacology
November 14, 2022
10.3389/fphar.2022.1031890
Cited by 47

Related Papers

Glycogen accumulation and phase separation drives liver tumor initiation
|Cell|2021|311
Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation
|Redox Biology|2022|238
Oxidative Stress and 4-hydroxy-2-nonenal (4-HNE): Implications in the Pathogenesis and Treatment of Aging-related Diseases
|Journal of Immunology Research|2022|182
Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression
|Advanced Science|2023|170
General Anesthesia vs Conscious Sedation for Endovascular Treatment in Patients With Posterior Circulation Acute Ischemic Stroke
|JAMA Neurology|2022|144